No abstract

Here, we report glutathione-protected water-soluble copper nanoclusters (Cu8 NCs) with excellent properties of high stability, large Stokes shift, and low toxicity. The molecular formula and structure of the Cu8 NCs were confirmed through good agreement between spectroscopic results and theoretical calculations. The origin of optical properties and chemical stability of the Cu8 NCs was determined through natural bond orbital analysis combined with time-dependent density functional theory calculations. It was found that the fluorescence emission and quantum yields of Cu8 NCs could be effectively enhanced by aluminum­(III) ions (Al3+) through the aggregation-induced enhanced emission mechanism. On the basis of the strong reaction of Al3+ with F–, the enhanced fluorescence of the obtained Cu8 NC-Al3+ ensemble could be selectively turned off by fluoride ions (F–), achieving highly sensitive detection of F– in aqueous with a detection limit of 0.16 μM. Also, the fluorescence of Cu8 NC-Al3+ ensemble quenched by F– could be enhanced again upon binding additional Al3+. In addition, the proposed Cu8 NC-Al3+ ensemble with enhanced fluorescence was used for bioimaging in vitro and in vivo. These results indicated that Cu8 NCs are promising materials for sequential sensing and bioimaging in the future.

No abstract

No abstract

TNF receptor-associated factors (TRAFs) are signaling adaptor proteins that play a crucial role in regulating cellular receptors’ signaling transduction to downstream pathways and exert multifaceted roles in regulating signaling pathways, cell survival, and carcinogenesis. The 13-cis-retinoic acid (RA), an active metabolite of vitamin A, exhibits anti-cancer properties, but the development of retinoic acid resistance poses a challenge in clinical application. This study aimed to investigate the relationship between TRAFs and retinoic acid sensitivity in various cancers. Here, we revealed that TRAFs’ expression varied significantly across The Cancer Genome Atlas (TCGA) cancer cohorts and human cancer cell lines. Additionally, inhibiting TRAF4, TRAF5, or TRAF6 improved retinoic acid sensitivity and reduced colony formation in ovarian cancer and melanoma cells. Mechanistically, knocking down TRAF4, TRAF5, or TRAF6 in retinoic acid-treated cancer cell lines increased the levels of procaspase 9 and induced cell apoptosis. Further in vivo studies using the SK-OV-3 and MeWo xenograft models confirmed the anti-tumor effects of TRAF knockdown combined with retinoic acid treatment. These findings support that combination therapy with retinoic acid and TRAF silencing may offer significant therapeutic advantages in treating melanoma and ovarian cancers.